Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    15152059 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy;   Coronary Artery Disease;   Myocardial Diseases
Intervention: Device: Blue Egg Device
2 Recruiting Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects
Condition: Heart Failure
Interventions: Drug: Testosterone undecanoate;   Drug: Saline isotonic solution
3 Recruiting Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy
Conditions: Heart Failure;   Resynchronization Therapy;   Assessment of Acute CRT Response
Intervention: Procedure: Cardiac resynchronization therapy device implantation
4 Not yet recruiting Electrophysiological Optimization of Left Ventricular Lead Placement in CRT
Condition: Congestive Heart Failure
Intervention: Device: Cardiac Resynchronization Therapy (St. Jude Qaudripolar LV lead)
5 Completed Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure
Condition: Congestive Heart Failure
Intervention: Device: Cardiac Resynchronization Therapy with & without defibrillator
6 Recruiting A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)
Conditions: Systolic Heart Failure;   Sudden Cardiac Death
Intervention: Behavioral: ICD Decision Aid Toolkit
7 Terminated BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Condition: Congestive Heart Failure
Interventions: Drug: Beta blocker (carvedilol or metoprolol succinate);   Procedure: CRT (cardiac resynchronization therapy)

Indicates status has not been verified in more than two years